Albany, NY -- (SBWIRE) -- 12/19/2017 -- The opportunity in the global transdermal scopolamine market was pegged at US$330.0 mn in 2015 and is poised to reach a valuation of US$585.3 mn by the end of 2024, progressing at a healthy CAGR of 6.70% between 2016 and 2024.

The Global Transdermal Scopolamine Market is segmented on the basis of expression system, by Geographiy, region.

Geographically, the worldwide transdermal scopolamine market is classified into Latin America, North America, the Middle East and Africa, Europe, and Asia Pacific. With a well-established healthcare industry, high healthcare expenditure, and soaring usage of transdermal scopolamine in surgeries and post-operative recovery, North America has been leading the global market.

With the increasing expenditure on healthcare, infrastructural developments in the healthcare industry, and the rising emphasis on community healthcare in emerging economies, such as China and India, Asia Pacific is expected to provide the most promising growth opportunities to players in the near future. The number of small- and medium- scale players, offering their transdermal scopolamine patches in this region, has increased substantially, making a competitive environment, which is likely to drive the Asia Pacific market for transdermal scopolamine further in the years to come. Amongst other, Latin America and the Middle East and Africa are anticipated to witness steady growth in their markets for transdermal scopolamine over the coming years, thanks to the rising number of travelers and the increasing focus of key industry players on these regions.

Summary of Table of Content:
1. Preface
2. Assumptions and Research Methodology
3. Executive Summary: Global Transdermal Scopolamine Market
4. Market Overview
5. Global Transdermal Scopolamine Market Analysis and Forecasts, By Region
6. North America Transdermal Scopolamine Market Analysis and Forecast
7. Europe Transdermal Scopolamine Market Analysis and Forecast
8. Asia Pacific Transdermal Scopolamine Market Analysis and Forecast
9. Latin America Transdermal Scopolamine Market Analysis and Forecast
10. Middle East & Africa Transdermal Scopolamine Market Analysis and Forecast
11. Competition Landscape
12. Key Take Away

Request to Browse Full Table of Content, figure and Tables @
https://www.transparencymarketresearch.com/report-toc/22322